News Daily News More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin L.A. McKeown February 14, 2025
News Daily News Potential Contributors to ESUS Explored in New Consensus Statement Todd Neale May 14, 2024
News Conference News ESOC 2023 ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy Todd Neale May 25, 2023
News Daily News Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke Todd Neale December 21, 2022
News Daily News Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions L.A. McKeown May 06, 2022
News Daily News Predictors of AF May Help Guide Care After Stroke of Unknown Cause Caitlin E. Cox October 26, 2021
News Daily News Nonstenotic Intracranial Plaque: An Underrecognized Source of Embolic Stroke Todd Neale February 10, 2021
News Daily News Enlarged Left Atria Can ID Patients With ESUS Who May Benefit From a DOAC Todd Neale April 08, 2019
News Daily News European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure Yael L. Maxwell November 01, 2018
News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin L.A. McKeown May 16, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Daily News Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early Todd Neale October 09, 2017